|
|
||||||||
a Department of Emergency and Organ Transplant, Division of Cardiac Surgery, University of Bari, Bari, Italy
b Department of Biomedical Sciences, Section of General and Experimental Pathology, University of Bari, Bari, Italy
Accepted for publication October 15, 2009.
* Address correspondence to Dr Paparella, University of Bari, Division of Cardiac Surgery, Dipartimento di Emergenza e Trapianti di Organo (DETO), Piazza Giulio Cesare 11, Bari, 70124, Italy (Email: dpaparella{at}cardiochir.uniba.it).
Background: To date, no study has tested the effect of different heparin dosages on the hemostatic changes during off-pump coronary artery bypass graft (OPCABG) surgery, and a wide variety of empirical anticoagulation protocols are being applied. We tested the effect of two different heparin dosages on the activation of the hemostatic system in patients undergoing OPCABG procedures.
Methods: Forty-two patients eligible for OPCABG procedures were assigned in a randomized fashion to low-dose heparin (150 IU/kg) or high-dose heparin (300 IU/kg). Prothrombin fragment 1+2, plasmin/alpha2-plasmin inhibitor complex, D-dimer, soluble tissue factor, tissue factor pathway inhibitor, total thrombin activatable fibrinolysis inhibitor (TAFI), and activated TAFIa were assayed by specific enzyme-linked immunosorbent assays at six different timepoints, before, during, and after surgery. Platelet function was evaluated by means of an in vitro bleeding time test, platelet function analyzer-100.
Results: The OPCABG surgery was accompanied by significant changes of all plasma biomarkers, indicative of systemic activation of coagulation and fibrinolysis. A significant increase in circulating TAFIa was detected perioperatively and postoperatively, and multiple regression analysis indicated that prothrombin F1+2 but not plasmin/alpha2-antiplasmin complex was independently associated with TAFIa level. Platelet function analyzer-100 values did not change significantly after OPCABG. All hemostatic changes were similar in the two heparin groups, even perioperatively, when the difference in anticoagulation was maximal.
Conclusions: Both early and late hemostatic changes, including TAFI activation, are similarly affected in the low-dose and high-dose heparin groups, suggesting that the increase in heparin dosage is not accompanied by a better control of clotting activation during OPCABG surgery.
Related Article
Ann. Thorac. Surg. 2010 89: 427-428.
This article has been cited by other articles:
![]() |
S. Rasoli, M. Zeinah, T. Athanasiou, and A. Kourliouros Optimal intraoperative anticoagulation strategy in patients undergoing off-pump coronary artery bypass Interact CardioVasc Thorac Surg, February 3, 2012; (2012) ivs003v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lison, W. Dietrich, S. Braun, J. Boehm, T. Schuster, A. Englhard, A. Perchuc, M. Spannagl, and R. Busley Enhanced Thrombin Generation After Cardiopulmonary Bypass Surgery Anesth. Analg., January 1, 2011; 112(1): 37 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shore-Lesserson Invited Commentary Ann. Thorac. Surg., February 1, 2010; 89(2): 427 - 428. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |